Logo

American Heart Association

  49
  0


Final ID:

BTK and BTA: How is Promise II and DVA Making an impact?

  • Shishehbor, Mehdi  ( University Hospitals of Cleveland , Cleveland , Ohio , United States )
  • Clair, Daniel  ( PRISMA HEALTH USC MEDICAL GROUP , Columbia , South Carolina , United States )
  • Derubertis, Brian  ( Weill Cornell Medicine , New York , New York , United States )
  • Author Disclosures:
    Mehdi Shishehbor: DO have relevant financial relationships ; Consultant:Medtronic:Active (exists now) ; Consultant:AdvNanoT (ANT):Active (exists now) ; Consultant:Inquis Medical:Active (exists now) ; Consultant:Inari:Active (exists now) ; Consultant:Boston Scientific:Active (exists now) ; Consultant:Abbott Vascular:Active (exists now) | Daniel Clair: No Answer | Brian DeRubertis: DO NOT have relevant financial relationships
Meeting Info:

Scientific Sessions 2025

2025

New Orleans, Louisiana

Session Info:

TCT at AHA: Hot Topics in PAD Intervention

Saturday, 11/08/2025 , 01:30PM - 02:45PM

Cardiovascular Seminar

More abstracts on this topic:
Atherectomy/IVL: What is Optimal Lesion Preparation for the SFA?

Li Jun, Armstrong Ehrin, Finn Matthew

BTK Drug Coated Balloons: We might have scaffolds, but we Need Them More Than Ever

Schneider Peter, Krishnan Prakash, Shammas Nicolas, Mathews Santhosh

You have to be authorized to contact abstract author. Please, Login
Not Available